Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Consulting Pharmacist Failed to Identify Medication Administration Outside Physician Parameters

Overland Park, Kansas Survey Completed on 06-26-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that the consulting pharmacist identified and reported instances where a resident received midodrine outside of the physician-ordered parameters. The resident had multiple diagnoses, including cognitive communication deficit, hypotension, edema, muscle weakness, and required assistance with personal care. Physician orders specified that midodrine should not be administered if the resident's systolic blood pressure (SBP) exceeded 140 mmHg. However, review of the Medication Administration Record and Treatment Administration Record over a 45-day period showed that midodrine was administered eight times when the resident's SBP was above the ordered threshold. Further review of the Monthly Medication Reviews from September 2024 to May 2025 revealed no evidence that the consulting pharmacist identified or reported these deviations from the physician's order. Interviews with facility staff confirmed the expectation that the pharmacist should have recognized and reported the medication administration outside of the prescribed parameters. Additionally, the facility was unable to provide a policy outlining the pharmacy's responsibility for monthly medication reviews.

An unhandled error has occurred. Reload 🗙